CABALETTA BIO INC (CABA) Stock Earnings & Estimates
USA - NASDAQ:CABA - US12674W1099 - Common Stock
2.38 USD
+0.02 (+0.85%)
2.37 USD
-0.01 (-0.42%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 2,155.57% | N/A 285.38% | N/A 118.26% | N/A 61.00% | N/A 18.84% | |||||||||
| EBITDA YoY % growth | N/A | N/A | -18.58M | -33.48M -80.19% | -45.58M -36.14% | -52.96M -16.19% | -73.234M -38.28% | -120.328M -64.31% | N/A -48.21% | N/A -16.07% | N/A -12.85% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -250K | -6.19M -2,376.00% | -18.68M -201.78% | -33.83M -81.10% | -46.31M -36.89% | -54.14M -16.91% | -74.66M -37.90% | -125.141M -67.61% | N/A -42.94% | N/A -11.01% | N/A -11.38% | N/A 13.17% | N/A 55.63% | N/A 345.10% | N/A 122.16% | N/A 30.39% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.44 68.09% | -1.80 -25.00% | -1.81 -0.56% | -1.65 8.84% | -2.34 -41.82% | N/A -5.31% | N/A 26.83% | N/A 10.54% | N/A 23.90% | N/A 56.79% | N/A 265.38% | N/A 217.44% | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.50 19.26% | -0.53 19.03% | -0.46 35.64% | -0.43 41.04% | -0.40 20.13% | -0.39 25.71% |
| Revenue Q2Q % growth | 1.7M | 1.7M | ||||
| EBITDA Q2Q % growth | -48.396M -52.17% | -50.541M -74.45% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -45.715M -38.34% | -48.324M -43.03% | -48.246M -29.92% | -49.878M -9.61% | -50.388M -10.22% | -50.796M -5.12% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.73 -30.36% | -0.66 | -0.07 | -10.16% |
| Q1 2025 Q2Q % growth | -0.71 -39.22% | -0.67 | -0.04 | -6.36% |
| Q4 2024 Q2Q % growth | -0.65 -41.30% | -0.64 | -0.01 | -1.02% |
| Q3 2024 Q2Q % growth | -0.62 -67.57% | -0.61 | -0.01 | -1.96% |
| Q2 2024 Q2Q % growth | -0.56 -51.35% | -0.56 | 0.00 | -0.22% |
| Q1 2024 Q2Q % growth | -0.51 -13.33% | -0.49 | -0.02 | -5.13% |
| Q4 2023 Q2Q % growth | -0.46 11.54% | -0.40 | -0.06 | -14.93% |
| Q3 2023 Q2Q % growth | -0.37 5.13% | -0.41 | 0.04 | 10.13% |
| Q2 2023 Q2Q % growth | -0.37 17.78% | -0.45 | 0.08 | 18.02% |
| Q1 2023 Q2Q % growth | -0.45 | -0.49 | 0.04 | 8.09% |
| Q4 2022 Q2Q % growth | -0.52 -6.12% | -0.46 | -0.06 | -12.84% |
| Q3 2022 Q2Q % growth | -0.39 13.33% | -0.49 | 0.10 | 20.62% |
| Q2 2022 Q2Q % growth | -0.45 | -0.51 | 0.06 | 12.60% |
| Q1 2022 Q2Q % growth | -0.45 -9.76% | -0.61 | 0.16 | 25.98% |
| Q4 2021 Q2Q % growth | -0.49 -22.50% | -0.62 | 0.13 | 20.60% |
| Q3 2021 Q2Q % growth | -0.45 -25.00% | -0.51 | 0.06 | 12.12% |
| Q2 2021 Q2Q % growth | -0.45 -28.57% | -0.51 | 0.06 | 12.25% |
| Q1 2021 Q2Q % growth | -0.41 -24.24% | -0.47 | 0.06 | 12.62% |
| Q4 2020 Q2Q % growth | -0.40 -21.21% | -0.37 | -0.03 | -8.18% |
| Q3 2020 Q2Q % growth | -0.36 83.41% | -0.45 | 0.09 | 19.79% |
| Q2 2020 Q2Q % growth | -0.35 | -0.40 | 0.05 | 12.24% |
| Q1 2020 Q2Q % growth | -0.33 | -0.23 | -0.10 | -41.28% |
| Q4 2019 Q2Q % growth | -0.33 | -0.66 | 0.33 | 50.23% |
| Q3 2019 Q2Q % growth | -2.17 | -1.36 | -0.81 | -59.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 4.25M | -4.25M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 25.59% | -1.42% | 0.43% |
| Revenue | -100% | -100% | -100% | -100% |